The WACC of Charmacy Pharmaceutical Co Ltd (2289.HK) is 5.8%.
| Range | Selected | |
| Cost of equity | 6.80% - 10.60% | 8.70% |
| Tax rate | 25.60% - 25.90% | 25.75% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 5.0% - 6.7% | 5.8% |
| Category | Low | High |
| Long-term bond rate | 2.9% | 3.4% |
| Equity market risk premium | 6.0% | 7.0% |
| Adjusted beta | 0.66 | 0.96 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 6.80% | 10.60% |
| Tax rate | 25.60% | 25.90% |
| Debt/Equity ratio | 1.33 | 1.33 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 5.0% | 6.7% |
| Selected WACC | 5.8% | |
The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.
This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.
Here’s how we figure out the cost of equity for 2289.HK:
cost_of_equity (8.70%) = risk_free_rate (3.15%) + equity_risk_premium (6.50%) * adjusted_beta (0.66) + risk_adjustments (0.25%)
We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.